Artículos por temáticas

Minimally invasive motor cortex stimulation for Parkinson's disease.

Lavano A, Guzzi G, DE Rose M, Romano M, Della Torre A, Vescio G, Deodato F, Lavano F, Volpentesta G.

J Neurosurg Sci. 2017 Feb;61(1):77-87.

Mechanisms of Parkinson's Disease: Lessons from Drosophila.

Hewitt VL, Whitworth AJ.

Curr Top Dev Biol. 2017;121:173-200. doi: 10.1016/bs.ctdb.2016.07.005.

Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.

Cova I, Di Battista ME, Vanacore N, Papi CP, Alampi G, Rubino A, Valente M, Meco G, Contri P, Di Pucchio A, Lacorte E, Priori A, Mariani C, Pomati S.

Parkinsonism Relat Disord. 2017 Jan;34:38-42. doi: 10.1016/j.parkreldis.2016.10.020.

Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.

Baba T, Hosokai Y, Nishio Y, Kikuchi A, Hirayama K, Suzuki K, Hasegawa T, Aoki M, Takeda A, Mori E.

J Neurol Sci. 2017 Jan 15;372:288-293. doi: 10.1016/j.jns.2016.11.068.

Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.

Auffret M, Le Jeune F, Maurus A, Drapier S, Houvenaghel JF, Robert GH, Sauleau P, Vérin M.

J Neurol Sci. 2017 Jan 15;372:279-287. doi: 10.1016/j.jns.2016.11.080.

Decision-making performance in Parkinson's disease correlates with lateral orbitofrontal volume.

Kobayakawa M, Tsuruya N, Kawamura M.

J Neurol Sci. 2017 Jan 15;372:232-238. doi: 10.1016/j.jns.2016.11.046.

Lower body mass index is associated with orthostatic hypotension in Parkinson's disease.

Nakamura T, Suzuki M, Ueda M, Hirayama M, Katsuno M.

J Neurol Sci. 2017 Jan 15;372:14-18. doi: 10.1016/j.jns.2016.11.027.

Corrigendum to Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define proteomic events of the novel paradigm for Alzheimer's with metals as primary disease cause [Med. Hypotheses 85 (2015) 779-790].

Cavaleri F.

Med Hypotheses. 2017 Jan;98:5. doi: 10.1016/j.mehy.2016.10.022. No abstract available.

Enhanced neuroprotection with decellularized brain extracellular matrix containing bFGF after intracerebral transplantation in Parkinson's disease rat model.

Lin Q, Wong HL, Tian FR, Huang YD, Xu J, Yang JJ, Chen PP, Fan ZL, Lu CT, Zhao YZ.

Int J Pharm. 2017 Jan 30;517(1-2):383-394. doi: 10.1016/j.ijpharm.2016.12.028.

Characteristics of spinopelvic alignment in Parkinson's disease: Comparison with adult spinal deformity.

Watanabe K, Hirano T, Katsumi K, Ohashi M, Shoji H, Hasegawa K, Yamazaki A, Ishikawa A, Koike R, Endo N, Nishizawa M, Shimohata T.

J Orthop Sci. 2017 Jan;22(1):16-21. doi: 10.1016/j.jos.2016.09.013.

Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease.

Yeung PK, Lai AK, Son HJ, Zhang X, Hwang O, Chung SS, Chung SK.

Neurobiol Aging. 2017 Feb;50:119-133. doi: 10.1016/j.neurobiolaging.2016.11.008.

The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot.

Mata IF, Davis MY, Lopez AN, Dorschner MO, Martinez E, Yearout D, Cholerton BA, Hu SC, Edwards KL, Bird TD, Zabetian CP.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):113. doi: 10.1002/ajmg.b.32510. No abstract available.

iTrack: instrumented mobile electrooculography (EOG) eye-tracking in older adults and Parkinson's disease.

Stuart S, Hickey A, Galna B, Lord S, Rochester L, Godfrey A.

Physiol Meas. 2017 Jan;38(1):N16-N31. doi: 10.1088/1361-6579/38/1/N16.

Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.

Geng X, Zhang J, Jiang Y, Ashkan K, Foltynie T, Limousin P, Zrinzo L, Green A, Aziz T, Brown P, Wang S.

Neurobiol Dis. 2017 Feb;98:100-107. doi: 10.1016/j.nbd.2016.12.006.

The FBXO7 homologue nutcracker and binding partner PI31 in Drosophila melanogaster models of Parkinson's disease.

Merzetti EM, Dolomount LA, Staveley BE.

Genome. 2017 Jan;60(1):46-54. doi: 10.1139/gen-2016-0087.